My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 104

    1.

    Oropharyngeal excretion of Epstein-Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts.

    Chang RS, Lewis JP, Reynolds RD, Sullivan MJ, Neuman J.

    Ann Intern Med. 1978 Jan;88(1):34-40.PMID: 202183 [PubMed - indexed for MEDLINE]Related articles

    2.

    A prospective study of oropharyngeal excretion of Epstein-Barr virus in renal homograft recipients.

    Chatterjee SN, Chang RS.

    Scand J Infect Dis. 1982;14(2):95-8.PMID: 6285453 [PubMed - indexed for MEDLINE]Related articles

    3.

    Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.

    Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS.

    Cancer Res. 1981 Nov;41(11 Pt 1):4253-61.PMID: 6272971 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs.

    Strauch B, Andrews LL, Siegel N, Miller G.

    Lancet. 1974 Feb 16;1(7851):234-7. No abstract available. PMID: 4130246 [PubMed - indexed for MEDLINE]Related articles

    5.

    Role of cytomegalovirus and Epstein-Barr virus in patients with de novo colon cancer after renal transplantation.

    Adani GL, Baccarani U, Lorenzin D, Bresadola V, Currò G, Sainz M, Gropuzzo M, Montanaro D, Tulissi P, Risaliti A, Bresadola F.

    Tumori. 2006 May-Jun;92(3):219-21.PMID: 16869239 [PubMed - indexed for MEDLINE]Related articles

    6.

    Catalogue of Epstein-Barr virus (EBV) receptors on human malignant and non-malignant hematopoietic cell lines.

    Tatsumi E, Harada S, Kuszynski C, Volsky D, Minowada J, Purtilo DT.

    Leuk Res. 1985;9(2):231-8.PMID: 2985880 [PubMed - indexed for MEDLINE]Related articles

    7.

    Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B virus carriers with hematologic malignancies.

    Ohtsu T, Sai T, Oka M, Sugai Y, Tobinai K.

    Jpn J Clin Oncol. 1991 Oct;21(5):360-5.PMID: 1753416 [PubMed - indexed for MEDLINE]Related articles

    8.

    Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder.

    Preiksaitis JK, Diaz-Mitoma F, Mirzayans F, Roberts S, Tyrrell DL.

    J Infect Dis. 1992 Nov;166(5):986-94.PMID: 1328412 [PubMed - indexed for MEDLINE]Related articles

    9.

    Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression.

    Ellis D, Jaffe R, Green M, Janosky JJ, Lombardozzi-Lane S, Shapiro R, Scantlebury V, Vivas C, Jordan ML.

    Transplantation. 1999 Oct 15;68(7):997-1003.PMID: 10532541 [PubMed - indexed for MEDLINE]Related articles

    10.

    Serial detection of Epstein-Barr virus DNA in sera and peripheral blood leukocyte samples of pediatric renal allograft recipients with persistent mononucleosis-like symptoms defines patients at risk to develop post-transplant lymphoproliferative disease.

    Campe H, Jaeger G, Abou-Ajram C, Nitschko H, Griebel M, Montoya C, Klare B, Koszinowski U.

    Pediatr Transplant. 2003 Feb;7(1):46-52.PMID: 12581328 [PubMed - indexed for MEDLINE]Related articles

    11.

    Direct visualization of enveloped Epstein-Barr Herpesvirus in throat washing with leukocyte-transforming activity.

    Lipman M, Andrews L, Niederman J, Miller G.

    J Infect Dis. 1975 Nov;132(5):520-3.PMID: 171319 [PubMed - indexed for MEDLINE]Related articles

    12.

    Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.

    Ho M, Miller G, Atchison RW, Breinig MK, Dummer JS, Andiman W, Starzl TE, Eastman R, Griffith BP, Hardesty RL, et al.

    J Infect Dis. 1985 Nov;152(5):876-86.PMID: 2995512 [PubMed - indexed for MEDLINE]Related articles

    13.

    Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.

    Mentzer SJ, Perrine SP, Faller DV.

    Transpl Infect Dis. 2001 Sep;3(3):177-85. Review.PMID: 11493400 [PubMed - indexed for MEDLINE]Related articles

    14.

    Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient.

    Hunt BJ, Thomas JA, Burke M, Walker H, Yacoub M, Crawford DH.

    Transplantation. 1996 Sep 27;62(6):869-72.PMID: 8824493 [PubMed - indexed for MEDLINE]Related articles

    15.

    Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.

    Roychowdhury S, Baiocchi RA, Vourganti S, Bhatt D, Blaser BW, Freud AG, Chou J, Chen CS, Xiao JJ, Parthun M, Chan KK, Eisenbeis CF, Ferketich AK, Grever MR, Chen CS, Caligiuri MA.

    J Natl Cancer Inst. 2004 Oct 6;96(19):1447-57.PMID: 15467034 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.

    Walker RC, Paya CV, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, Daly RC, McGregor CG.

    J Heart Lung Transplant. 1995 Mar-Apr;14(2):214-21.PMID: 7779838 [PubMed - indexed for MEDLINE]Related articles

    17.

    Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation.

    van Esser JW, Niesters HG, Thijsen SF, Meijer E, Osterhaus AD, Wolthers KC, Boucher CA, Gratama JW, Budel LM, van der Holt B, van Loon AM, Löwenberg B, Verdonck LF, Cornelissen JJ.

    Br J Haematol. 2001 Jun;113(3):814-21.PMID: 11380475 [PubMed - indexed for MEDLINE]Related articles

    18.

    Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

    Hanto DW, Gajl-Peczalska KJ, Frizzera G, Arthur DC, Balfour HH Jr, McClain K, Simmons RL, Najarian JS.

    Ann Surg. 1983 Sep;198(3):356-69.PMID: 6311121 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact.

    Gray J, Wreghitt TG, Pavel P, Smyth RL, Parameshwar J, Stewart S, Cary N, Large S, Wallwork J.

    J Heart Lung Transplant. 1995 Jul-Aug;14(4):640-6.PMID: 7578169 [PubMed - indexed for MEDLINE]Related articles

    20.

    Epstein-Barr virus related central nervous system lymphoma in a child after renal transplantation.

    van Diemen-Steenvoorde R, Donckerwolcke RA, Kluin PM, Kapsenberg JG, Lepoutre JM, Fleer A, Kuis W, Stoop JW.

    Int J Pediatr Nephrol. 1986 Jan-Mar;7(1):55-8.PMID: 3007383 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity